News

The Federation of American Scientists- FAS has gone on to publish five policy recommendations so as to address the issues concerning AI when it comes to life sciences. It is well to be noted that the Bio X AI policy...

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces that it has entered into a material agreement with a biotechnology company developing genetic medicines. Under the terms of the agreement, Aptamer...

In all probabilities, it is expected that mergers & acquisitions in the pharma and life sciences sectors will hit a healthy level in 2024, with deals reaching $225 billion to $275 billion, according to PwC's new US Deals 2024...

Pharma companies in the US have come under fire yet again from the White House. This is the second time in two weeks that such a scenario has taken place. The Biden administration announced that several of drugmakers would...

ReciBioPharm, the advanced and emerging therapies business unit within Recipharm, and biotechnology firm Acuitas Therapeutics have today announced they are taking their partnership to the next level, and are ready to perform technology transfers and CGMP manufacturing for customers...

In 2022, the global market for pharmaceutical temperature-controlled packaging solutions happened to be valued at USD 578.9 million. It is, in all probabilities, set to reach almost USD 945.2 million by 2030, with a CAGR of 6.30% from 2022...

As per the recent projections, the market when it comes to temperature-controlled packaging solutions is most likely to reach almost $26.2 billion by 2030, thereby showcasing a robust yearly growth rate of more than 11.2%. It is well to be...